Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 1 (2004), Issue 5 (December)

1. Impaired processing of DNA photoproducts and ultraviolet hypermutability with loss of p16INK4a or p19ARF.
   J Natl Cancer Inst, 96(23): 1790-3. [Abstract] [Full-text]
2. Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells.
   Eur J Cancer, 40(18): 2829-36. [Abstract] [Full-text]
3. Prognostic significance of detecting micrometastases by tyrosinase RT/PCR in sentinel lymph node biopsies: lessons from 322 consecutive melanoma patients.
   Eur J Cancer, 40(18): 2812-9. [Abstract] [Full-text]
4. Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.
   Cancer Res, 64(23): 8773-7. [Abstract] [Full-text]
5. Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome.
   Cancer Res, 64(23): 8767-72. [Abstract] [Full-text]
6. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases.
   Cancer Causes Control, 15(9): 957-65. [Abstract] [Full-text]
7. Melanoma and lifetime UV radiation.
   Cancer Causes Control, 15(9): 893-902. [Abstract] [Full-text]
8. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
   Ann Surg Oncol, 11(12): 1079-84. [Abstract] [Full-text]
9. Developments in the management of uveal melanoma.
   Clin Experiment Ophthalmol, 32(6): 639-47. [Abstract] [Full-text]
10. Differentiation of human melanoma cells induced by cyanidin-3-O-beta-glucopyranoside.
    FASEB J, 18(15): 1940-2. [Abstract] [Full-text]
11. Geographic disparities in diagnostic screening for metastatic uveal melanoma.
    Ophthalmology, 111(12): 2254-8. [Abstract] [Full-text]
12. Interest of F-18 fluorodeoxyglucose positron emission tomography in the evaluation of vaginal malignant melanoma.
    Gynecol Oncol, 95(3): 765-8. [Abstract] [Full-text]
13. Hyperpolarized (3)He MRI of mouse lung.
    Magn Reson Med, 52(6): 1310-7. [Abstract] [Full-text]
14. Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity.
    Nat Biotechnol, 22(12): 1546-53. [Abstract] [Full-text]
15. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria.
    JAMA, 292(22): 2771-6. [Abstract] [Full-text]
16. IL-18 enhances SCF production of melanoma cells by regulating ROI and p38 MAPK activity.
    Immunol Lett, 96(2): 211-7. [Abstract] [Full-text]
17. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.
    Biomaterials, 26(15): 2685-94. [Abstract] [Full-text]
18. Regulation of gene expression in melanoma: new approaches for treatment.
    J Cell Biochem, 94(1): 25-38. [Abstract] [Full-text]
19. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry.
    Proteomics, 4(12): 4019-31. [Abstract] [Full-text]
20. Identification of proteins regulated by interferon-alpha in resistant and sensitive malignant melanoma cell lines.
    Proteomics, 4(12): 3998-4009. [Abstract] [Full-text]
21. High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity.
    Cancer Immunol Immunother, 54(2): 141-8. [Abstract] [Full-text]
22. Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma.
    Onkologie, 27(6): 540-4. [Abstract] [Full-text]
23. Influence of mistletoe lectins and cytokines induced by them on cell proliferation of human melanoma cells in vitro.
    Toxicology, 207(1): 105-16. [Abstract] [Full-text]
24. Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses).
    Cancer Genet Cytogenet, 156(1): 74-6. [Abstract] [Full-text]
25. Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.
    Cancer, 101(12): 2809-16. [Abstract] [Full-text]
26. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
    Cancer Immunol Immunother, 54(2): 172-8. [Abstract] [Full-text]
27. Expression profiles of Id1 and p16 proteins in all-trans-retinoic acid-induced apoptosis and cell cycle re-distribution in melanoma.
    Cancer Lett, 217(1): 33-41. [Abstract] [Full-text]
28. Phase I/II trial of gene therapy with autologous tumor cells modified with tag7/PGRP-S gene in patients with disseminated solid tumors: miscellaneous tumors.
    Ann Oncol, 16(1): 162-8. [Abstract] [Full-text]
29. Phase II study of E7070 in patients with metastatic melanoma.
    Ann Oncol, 16(1): 158-61. [Abstract] [Full-text]
30. Population-based incidence rates of malignant melanoma of the vulva in Germany.
    Gynecol Oncol, 96(1): 216-21. [Abstract] [Full-text]
31. Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12.
    Cancer Gene Ther, 12(1): 72-83. [Abstract] [Full-text]
32. Synchronous cancer and metastatic melanoma of the breasts.
    Arch Gynecol Obstet, 270(4): 290-1. [Abstract] [Full-text]
33. Polymorphous vascular patterns in dermoscopy as a sign of malignant skin tumors. A case of an amelanotic melanoma and a porocarcinoma.
    Dermatology, 210(1): 58-9. [Abstract] [Full-text]
34. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma.
    Dermatology, 210(1): 39-44. [Abstract] [Full-text]
35. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
    Cancer Res, 64(24): 9167-71. [Abstract] [Full-text]
36. Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas.
    Cancer Res, 64(24): 8945-53. [Abstract] [Full-text]
37. Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion.
    Cancer Res, 64(24): 8924-31. [Abstract] [Full-text]
38. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Cancer Res, 64(24): 8795-9. [Abstract] [Full-text]
39. Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin.
    Vaccine, 23(7): 884-9. [Abstract] [Full-text]
40. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.
    Cancer Cell, 6(6): 565-76. [Abstract] [Full-text]
41. Refinement of the island pedicle flap: parallel placed release incisions to increase translation movement.
    Dermatol Surg, 30(12): 1595-8. [Abstract] [Full-text]
42. Successful treatment of persistent melanoma in situ with 5% imiquimod cream.
    Dermatol Surg, 30(12): 1543-5. [Abstract] [Full-text]
43. Acral malignant melanoma and striated palmoplantar keratoderma (Brunauer-Fohs-Siemens syndrome): a fortuitous association?
    Dermatol Surg, 30(12): 1539-42. [Abstract] [Full-text]
44. Local melanoma recurrence: a clarification of terminology.
    Dermatol Surg, 30(12): 1533-8. [Abstract] [Full-text]
45. Malignant melanoma arising in a pregnant African American woman with a congenital blue nevus.
    Dermatol Surg, 30(12): 1530-2. [Abstract] [Full-text]
46. Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential.
    J Cutan Pathol, 32(2): 125-30. [Abstract] [Full-text]
47. Melanoma or not? Cancer testis antigens may help.
    Br J Dermatol, 151(6): 1213-8. [Abstract] [Full-text]
48. Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patients.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(1): 109-14. [Abstract] [Full-text]
49. Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling.
    J Invest Dermatol, 123(6): 1151-61. [Abstract] [Full-text]
50. XAF1 expression is significantly reduced in human melanoma.
    J Invest Dermatol, 123(6): 1127-34. [Abstract] [Full-text]
51. An osteoid variant of cutaneous melanoma in a dog detected by S100 and melan a markers.
    J Vet Med A Physiol Pathol Clin Med, 51(9): 413-5. [Abstract] [Full-text]
52. Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy.
    Blood, 105(1): 241-50. [Abstract] [Full-text]
53. Diagnosis of melanoma in the elderly and surgical implications.
    Surg Oncol, 13(4): 211-21. [Abstract] [Full-text]
54. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells.
    J Med Chem, 47(27): 6914-20. [Abstract] [Full-text]
55. Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma.
    Mol Pharmacol, 67(1): 298-308. [Abstract] [Full-text]
56. Seasonal variation in the occurrence of cutaneous melanoma in Europe: influence of latitude. An analysis using the EUROCARE group of registries.
    Eur J Cancer, 41(1): 126-32. [Abstract] [Full-text]
57. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients.
    Eur J Cancer, 41(1): 118-25. [Abstract] [Full-text]
58. Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control.
    Eur J Cancer, 41(1): 104-17. [Abstract] [Full-text]
59. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure.
    Eur J Cancer, 41(1): 45-60. [Abstract] [Full-text]
60. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi.
    Eur J Cancer, 41(1): 28-44. [Abstract] [Full-text]
61. Indoor tanning by adolescents: prevalence, practices and policies.
    Eur J Cancer, 41(1): 20-7. [Abstract] [Full-text]
62. Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-alpha and translocating PKC-delta.
    Cancer Chemother Pharmacol, 55(3): 251-62. [Abstract] [Full-text]
63. Malignant melanoma with gall bladder metastasis as a second neoplasm in the course of prostate cancer.
    Pathol Oncol Res, 10(4): 243-5. [Abstract] [Full-text]
64. Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy.
    Ann Thorac Surg, 79(1): e1-2. [Abstract] [Full-text]
65. Short and highly efficient synthetic promoters for melanoma-specific gene expression.
    FEBS Lett, 579(1): 153-6. [Abstract] [Full-text]
66. Conjunctival melanoma in the Netherlands: a nationwide study.
    Invest Ophthalmol Vis Sci, 46(1): 75-82. [Abstract] [Full-text]
67. Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.
    Invest Ophthalmol Vis Sci, 46(1): 24-30. [Abstract] [Full-text]
68. Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
    Clin Cancer Res, 10(24): 8396-404. [Abstract] [Full-text]
69. Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cells.
    Clin Cancer Res, 10(24): 8371-9. [Abstract] [Full-text]
70. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
    J Am Acad Dermatol, 52(1): 92-100. [Abstract] [Full-text]
71. Melanoma detection in British Columbia, Canada.
    J Am Acad Dermatol, 52(1): 48-54. [Abstract] [Full-text]

© 2004-2010 Melanoma Research Today. All Rights Reserved.